• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-AlF-NOTA-奥曲肽PET/CT检测出的罕见腹膜间皮瘤病例

A Rare Case of Peritoneal Mesothelioma Detected by 18 F-AlF-NOTA-Octreotide PET/CT.

作者信息

Hou Guozhu, Cheng Xin, Jiang Yuanyuan, Zheng Rong, Wang Xuejuan

机构信息

Department of Nuclear Medicine (PET-CT Center), National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Clin Nucl Med. 2025 May 1;50(5):446-447. doi: 10.1097/RLU.0000000000005681. Epub 2025 Jan 23.

DOI:10.1097/RLU.0000000000005681
PMID:39853210
Abstract

We present a case of 37-year-old man with multiple masses in the abdominal and pelvic cavity who underwent 18 F-AlF-NOTA-octreotide PET/CT. The masses demonstrated heterogeneously increased uptake on 18 F-AlF-NOTA-octreotide PET/CT and were suggestive of neuroendocrine tumor. However, the histopathological examinations confirmed the masses to be peritoneal mesothelioma. This case indicated that peritoneal mesothelioma should be kept in mind as one of the differential diagnoses for 18 F-AlF-NOTA-octreotide-avid tumors.

摘要

我们报告一例37岁男性,其腹腔和盆腔有多个肿块,接受了18F-AlF-NOTA-奥曲肽PET/CT检查。这些肿块在18F-AlF-NOTA-奥曲肽PET/CT上显示摄取不均匀增加,提示为神经内分泌肿瘤。然而,组织病理学检查证实这些肿块为腹膜间皮瘤。该病例表明,腹膜间皮瘤应作为18F-AlF-NOTA-奥曲肽摄取阳性肿瘤的鉴别诊断之一予以考虑。

相似文献

1
A Rare Case of Peritoneal Mesothelioma Detected by 18 F-AlF-NOTA-Octreotide PET/CT.18F-AlF-NOTA-奥曲肽PET/CT检测出的罕见腹膜间皮瘤病例
Clin Nucl Med. 2025 May 1;50(5):446-447. doi: 10.1097/RLU.0000000000005681. Epub 2025 Jan 23.
2
A Rare Case of Follicular Dendritic Cell Tumor of the Abdominal Cavity Visualized by 18 F-AlF-NOTA-Octreotide PET/CT.18F-AIF-NOTA-Octreotide PET/CT 显像腹部腔室滤泡树突细胞肿瘤 1 例罕见病例
Clin Nucl Med. 2024 Dec 1;49(12):1118-1119. doi: 10.1097/RLU.0000000000005369. Epub 2024 Jul 3.
3
Clinical impact of using [F]AlF-NOTA-octreotide PET/CT instead of [Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.使用[F]AlF-NOTA-奥曲肽PET/CT而非[Ga]Ga-DOTA-SSA PET/CT的临床影响:一项多中心前瞻性试验的次要终点分析
J Neuroendocrinol. 2024 Aug;36(8):e13420. doi: 10.1111/jne.13420. Epub 2024 Jun 4.
4
Diagnostic performance and clinical impact of F-AlF-NOTA-octreotide in a large cohort of patients with neuroendocrine neoplasms: A prospective single-center study.F-AlF-NOTA-奥曲肽在一大群神经内分泌肿瘤患者中的诊断性能和临床影响:一项前瞻性单中心研究。
Theranostics. 2024 May 19;14(8):3213-3220. doi: 10.7150/thno.96762. eCollection 2024.
5
Direct comparison of [F]AlF-NOTA-JR11 and [F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist.直接比较 [F]AlF-NOTA-JR11 和 [F]AlF-NOTA-奥曲肽用于神经内分泌肿瘤的 PET 成像:拮抗剂与激动剂。
Nucl Med Biol. 2023 Mar-Apr;118-119:108338. doi: 10.1016/j.nucmedbio.2023.108338. Epub 2023 Mar 29.
6
F-AlF-NOTA-Octreotide Outperforms Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study.F-AlF-NOTA-奥曲肽在神经内分泌肿瘤患者中优于Ga-DOTATATE/NOC PET:一项前瞻性多中心研究的结果
J Nucl Med. 2023 Apr;64(4):632-638. doi: 10.2967/jnumed.122.264563. Epub 2022 Oct 20.
7
Preparation and Evaluation of [F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [Ga]Ga-DOTA/NOTA-NOC.[F]AlF-NOTA-NOC 的制备与评价及其用于神经内分泌肿瘤 PET 成像的研究:与 [Ga]Ga-DOTA/NOTA-NOC 的比较。
Molecules. 2022 Oct 12;27(20):6818. doi: 10.3390/molecules27206818.
8
18F-AlF-NOTA-octreotide PET/CT and 3D printing technology for precision diagnosis and treatment of phosphaturic mesenchymal tumors in patients with tumor-induced osteomalacia: two case reports.18F-氟化铝-NOTA-奥曲肽PET/CT及3D打印技术用于肿瘤诱导性骨软化症患者中磷尿性间叶肿瘤的精准诊断与治疗:两例病例报告
Front Endocrinol (Lausanne). 2024 Nov 20;15:1359975. doi: 10.3389/fendo.2024.1359975. eCollection 2024.
9
68 Ga-FAPI PET/CT Depicted Non-FDG-Avid Malignant Peritoneal Mesothelioma.68Ga-FAPI PET/CT显示非FDG摄取的恶性腹膜间皮瘤。
Clin Nucl Med. 2025 May 1;50(5):462-463. doi: 10.1097/RLU.0000000000005676. Epub 2025 Jan 20.
10
[F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [Ga]Ga-DOTATATE in neuroendocrine tumour patients.[F]AlF-NOTA-奥曲肽正电子发射断层显像:神经内分泌肿瘤患者的生物分布、剂量测定及与[Ga]Ga- DOTATATE的首次比较
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3033-3046. doi: 10.1007/s00259-020-04918-4. Epub 2020 Jul 2.

引用本文的文献

1
The clinical benefits of [F]AlF-NOTA-octreotide PET/CT in staging and restaging patients with gastroenteropancreatic neuroendocrine neoplasms: comparison of [F]FDG PET/CT.[F]AlF-NOTA-奥曲肽PET/CT在胃肠胰神经内分泌肿瘤患者分期及再分期中的临床应用:与[F]FDG PET/CT的比较
BMC Med Imaging. 2025 Jul 11;25(1):280. doi: 10.1186/s12880-025-01824-9.